All Tablets

dmscarepharma dmscaren scaled

Oral solid dose from a GMP manufacturer: immediate-release, modified-release, dispersible and chewable tablets, released against USP, EP, BP or CP monographs.

Tablets: what the published guidance says

Tablets are the default presentation for oral medicines on the WHO Model List, and the list writes dosage forms precisely: where a medicine is listed as a dispersible tablet for paediatric use, a standard compressed tablet is not an equivalent substitution for that programme.

  • Dispersible and standard tablets are separate lines on the Model List The 24th WHO Model List distinguishes tablet, dispersible tablet and chewable forms, and lists them at defined strengths. Dispensers substituting one for another in paediatric programmes is a documented risk that procurement specifications are meant to prevent. Source
  • Strength duplication on one market is called out explicitly For paracetamol oral liquids the Model List warns that carrying two near-identical strengths causes prescribing and dispensing errors. The same discipline applies to tablet strengths within a national programme. Source
  • Release testing is monograph-driven Assay, dissolution or disintegration, uniformity of dosage units and related substances are the core release tests for a compressed tablet. Which monograph applies is a commercial input, not an afterthought. Source

What to fix in the specification

  • Strength per tablet, expressed in the salt or base form you register
  • Immediate release, sustained release, dispersible, chewable or film-coated
  • Tablet weight, hardness, thickness and friability limits
  • Disintegration or dissolution limits per the nominated monograph
  • Blister (PVC/Alu, Alu/Alu) or HDPE bottle, with pack count
  • Artwork, embossing and break-line requirements

Questions buyers ask

Can you supply dispersible tablets for paediatric programmes?

Yes. Dispersible and chewable tablets are produced as distinct presentations with their own specification, because the WHO Model List treats them as separate lines from standard compressed tablets.

Which release profiles are available?

Immediate release, sustained or modified release, enteric-coated, dispersible, chewable and film-coated. The profile is fixed in the written specification before manufacture.

How is dissolution data handled for registration?

Dissolution method validation and comparative profile data are prepared as part of the dossier and follow the monograph or the method agreed with your authority.

Ordering and documentation

Every line is quoted against a written specification: monograph, strength, pack configuration, release tests and the documents that ship with the batch. Certificates of analysis, stability data and the GMP certificate accompany each consignment; dossier and registration support are provided where the market requires a filing.

Send a requirement · full product catalogue · therapeutic ranges

Reference information only. Published guidance is quoted for professional and regulatory-context purposes and is not medical advice or a prescribing recommendation.